NCT06786663
MALE Mamm Organoids
Recruiting · Not specified · Regina Elena Cancer Institute · registry updated 2025-01-22
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
Inclusion
- Men aged \>18 years
- Patients with histologically confirmed breast cancer with or without synchronous metastases, who will undergo the relevant surgical intervention
- Adequate biological material to be able to carry out the analyses described above
- Signing of the relevant informed consent form